Enhanced Efficacy of Cefiderocol With PolyTrim Combination Therapy in a Rabbit Model of Extensively Drug-Resistant Pseudomonas aeruginosa Keratitis
Investigative Ophthalmology & Visual Science · 19.05.2026 · 67 (5) · 48
DOI: 10.1167/iovs.67.5.48 ↗Kurz gefasst
Fachartikel in der Zeitschrift Investigative Ophthalmology & Visual Science, erschienen am 19.05.2026. Verfasst von Eric G Romanowski und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Charles T. Campbell Ophthalmic Microbiology Laboratory, UPMC Vision Institute, Department of Ophthalmology, University of Pittsburgh School of Me…. Hauptthemen laut MEDLINE: Pseudomonas Infections, Pseudomonas aeruginosa, Eye Infections, Bacterial, Cephalosporins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NEI NIH HHS.
Abstract (Originalsprache)
Purpose
The 2023 Pseudomonas aeruginosa keratitis outbreak linked to contaminated artificial tears underscored the need for new therapies against extensively drug-resistant ocular pathogens. In vitro data suggested additive or synergistic activity between the siderophore-cephalosporin cefiderocol (FDC) and either moxifloxacin (MOX) or polymyxin B sulfate (PB). Here, we tested whether combining FDC with the commercial formulations of MOX (0.5%) or PolyTrim (PT; PB 10,000 U/mL + trimethoprim 0.1%) improved in vivo outcomes.
Methods
New Zealand White rabbits were injected intrastromally with 5000 CFU of Pseudomonas aeruginosa strain CDC1270. After 16 hours, established infections were treated every 30 minutes for 8 hours with FDC, followed 5 minutes later by MOX or PT. Additional groups received monotherapies or saline. Bacterial burden (CFU/cornea) and anterior chamber cultures were determined, and ocular inflammation was assessed.
Results
FDC + MOX reduced bacterial burden by 2.8 log10 CFU, outperforming FDC and MOX monotherapies, although no eyes were sterilized. PT monotherapy produced a significant 3.2 log10 reduction in CFU. The FDC + PT combination yielded the most potent activity, with almost 6.9 log10 reduction and sterilization of 10 of 12 corneas. Notably, anterior chamber invasion occurred in saline and MOX groups but in none of the FDC-containing groups, and perforations were absent in all FDC and PT treatments.
Conclusions
FDC + PT was superior to monotherapies and to FDC + MOX, achieving frequent sterilization and preventing intraocular spread and corneal perforations. These data support PT alone or in combination with FDC as promising therapeutic candidates for the treatment of XDR P. aeruginosa keratitis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The Charles T. Campbell Ophthalmic Microbiology Laboratory, UPMC Vision Institute, Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States.
- Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, United States.
Förderung
- NEI NIH HHS
Zitieren
APA
Romanowski, E. G., Young, E. K., Mandell, J. B., Dhaliwal, D. K., Mammen, A., Jhanji, V., Zegans, M. E., & Shanks, R. M. Q. (2026). Enhanced Efficacy of Cefiderocol With PolyTrim Combination Therapy in a Rabbit Model of Extensively Drug-Resistant Pseudomonas aeruginosa Keratitis. Investigative Ophthalmology & Visual Science, 67(5), 48. https://doi.org/10.1167/iovs.67.5.48
Vancouver
Romanowski EG, Young EK, Mandell JB, Dhaliwal DK, Mammen A, Jhanji V, et al. Enhanced Efficacy of Cefiderocol With PolyTrim Combination Therapy in a Rabbit Model of Extensively Drug-Resistant Pseudomonas aeruginosa Keratitis. Investigative Ophthalmology & Visual Science. 2026;67(5):48. doi:10.1167/iovs.67.5.48
BibTeX
@article{Romanowski2026,
author = {Romanowski, Eric G and Young, Emily K and Mandell, Jonathan B and Dhaliwal, Deepinder K and Mammen, Alex and Jhanji, Vishal and Zegans, Michael E and Shanks, Robert M Q},
title = {Enhanced Efficacy of Cefiderocol With PolyTrim Combination Therapy in a Rabbit Model of Extensively Drug-Resistant Pseudomonas aeruginosa Keratitis},
journal = {Investigative Ophthalmology & Visual Science},
year = {2026},
volume = {67},
number = {5},
pages = {48},
doi = {10.1167/iovs.67.5.48}
}
EUVIMED